Adalta Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Hold
897
– – 0.1% 88
2026
Q2
$226K Hold
897
– – 0.1% 87
2026
Q1
$195K Hold
897
– – 0.09% 87
2025
Q4
$205K Sell
897
-19
-2% -$4.33K 0.09% 83
2025
Q3
$212K Hold
916
– – 0.1% 78
2025
Q2
$170K Hold
916
– – 0.09% 77
2025
Q1
$192K Buy
+916
New +$178K 0.1% 72

Other funds holding ABBV

Adalta Capital Management's ABBV Position: Q3 2026 in Review

Adalta Capital Management held its AbbVie (ABBV) position steady in Q3 2026 at 897 shares worth $235K. The position accounts for 0.1% of the portfolio, ranked #88.

Adalta Capital Management first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Adalta Capital Management held 897 shares of AbbVie worth $235K as of Q3 2026.
  • Adalta Capital Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.1% of Adalta Capital Management's portfolio in Q3 2026, its #88 holding.
  • Adalta Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Adalta Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.